TRACON Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
TRACON Pharmaceuticals, Inc.‘s stocks are currently a part of 17 hedge funds’ portfolios, which represents 26.13% of the total amount of its stocks outstanding. This makes up a total of 5.46M shares of TRACON Pharmaceuticals, Inc.. Compared to the previous quarter, the number fell by -44.35% or -4.35M shares fewer. As for the holding position changes, 23.53% (4) of current hedge fund investors increased the number of shares held, 23.53% (4) of current holders sold a part of the shares held, and 11.76% (2) closed the holdings completely. 1 hedge funds are new holders of TRACON Pharmaceuticals, Inc. stock in Q1 2023, it is 5.88% of total holders.
Hedge funds holding TRACON Pharmaceuticals (Q2 2018 – Q1 2023)
| Q2 2018 | 34 |
|---|---|
| Q3 2018 | 37 |
| Q4 2018 | 26 |
| Q1 2019 | 23 |
| Q2 2019 | 24 |
| Q3 2019 | 21 |
| Q4 2019 | 14 |
| Q1 2020 | 18 |
| Q2 2020 | 18 |
| Q3 2020 | 26 |
| Q4 2020 | 38 |
| Q1 2021 | 42 |
| Q2 2021 | 44 |
| Q3 2021 | 43 |
| Q4 2021 | 35 |
| Q1 2022 | 35 |
| Q2 2022 | 30 |
| Q3 2022 | 32 |
| Q4 2022 | 32 |
| Q1 2023 | 17 |
Hedge funds changes in TRACON Pharmaceuticals positions (Q2 2018 – Q1 2023)
| Q2 2018 | 5 | 14 | 10 | 4 | 1 |
|---|---|---|---|---|---|
| Q3 2018 | 5 | 10 | 11 | 2 | 9 |
| Q4 2018 | 4 | 8 | 3 | 15 | -4 |
| Q1 2019 | 5 | 5 | 3 | 8 | 2 |
| Q2 2019 | 6 | 4 | 4 | 5 | 5 |
| Q3 2019 | 1 | 6 | 4 | 4 | 6 |
| Q4 2019 | 12 | 0 | 2 | 19 | -19 |
| Q1 2020 | 9 | 2 | 3 | 5 | -1 |
| Q2 2020 | 3 | 8 | 1 | 3 | 3 |
| Q3 2020 | 13 | 3 | 4 | 5 | 1 |
| Q4 2020 | 15 | 12 | 4 | 3 | 4 |
| Q1 2021 | 13 | 11 | 9 | 9 | 0 |
| Q2 2021 | 7 | 6 | 14 | 5 | 12 |
| Q3 2021 | 9 | 11 | 9 | 8 | 6 |
| Q4 2021 | 3 | 8 | 9 | 10 | 5 |
| Q1 2022 | 5 | 11 | 7 | 5 | 7 |
| Q2 2022 | 2 | 6 | 7 | 7 | 8 |
| Q3 2022 | 3 | 4 | 7 | 1 | 17 |
| Q4 2022 | 7 | 5 | 7 | 5 | 8 |
| Q1 2023 | 1 | 4 | 4 | 2 | 6 |
Hedge funds changes in TRACON Pharmaceuticals stock options (Q2 2018 – Q1 2023)
| Q2 2018 | 0 | 0 |
|---|---|---|
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 106,000 | 14,000 |
| Q1 2021 | 152,000 | 464,000 |
| Q2 2021 | 130,000 | 225,000 |
| Q3 2021 | 439,000 | 204,000 |
| Q4 2021 | 826,000 | 193,000 |
| Q1 2022 | 748,000 | 80,000 |
| Q2 2022 | 125,000 | 47,000 |
| Q3 2022 | 52,000 | 0 |
| Q4 2022 | 63,133 | 2,639 |
| Q1 2023 | 68,418,000 | 1,000 |